title: Time to consider HPV vaccination after allogeneic stem cell transplantation.
authors.affiliation: Long- Term Follow-up Transplant Clinic (LTTC), Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232-5505, USA.
authors.forename: Sara K
authors.initials: SK
authors.lastname: Tedeschi
authors.forename: Bipin N
authors.initials: BN
authors.lastname: Savani
authors.forename: Madan
authors.initials: M
authors.lastname: Jagasia
authors.forename: Brian
authors.initials: B
authors.lastname: Engelhardt
authors.forename: Claudio
authors.initials: C
authors.lastname: Anasetti
authors.forename: A John
authors.initials: AJ
authors.lastname: Barrett
authors.forename: Stephanie
authors.initials: S
authors.lastname: Lee
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D014184:Transplantation, Homologous; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines